Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Neurogenetics|March 23, 2016
Mutations in HIVEP2 are associated with developmental delay, intellectual disability, and dysmorphic featuresHallie Steinfeld, Megan T Cho, Kyle Retterer, et al.Critical Care Medicine|May 28, 2026
Reducing Physical Restraint in the ICU: Multicenter Phase II Randomized Trial of a Novel Device Versus Traditional Wrist RestraintsRenee D Stapleton, Biren B Kamdar, Elizabeth A Colantuoni, et al.Journal of the American Heart Association|September 8, 2023
A Multicenter Analysis of Abnormal Chromosomal Microarray Findings in Congenital Heart DiseaseBenjamin J Landis, Lindsey R Helvaty, Gabrielle C Geddes, et al.Pediatric Cardiology|June 28, 2018
Predictors of Rapid Aortic Root Dilation and Referral for Aortic Surgery in Marfan SyndromeArvind Hoskoppal, Shaji Menon, Felicia Trachtenberg, et al.American Heart Journal|April 30, 2013
Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and losartan therapyRonald V Lacro, Lin T Guey, Harry C Dietz, et al.American Journal of Respiratory and Critical Care Medicine|July 13, 2026
Nutrition and Exercise in Critical Illness (NEXIS) trial: randomized trial of combined in-bed cycling and intravenous amino acid plus usual careDale M Needham, Daniel Clark Files, Catherine L Hough, et al.Journal of Pain and Symptom Management|May 20, 2022
Evolution of Investigating Informed Assent Discussions about CPR in Seriously Ill PatientsRenee D Stapleton, Dee W Ford, Katherine R Sterba, et al.American Journal of Medical Genetics. Part A|February 29, 2024
De novo variants predicting haploinsufficiency for DIP2C are associated with expressive speech delayThoa Ha, Angela Morgan, Meghan N Bartos, et al.The New England Journal of Medicine|November 19, 2014
Atenolol versus losartan in children and young adults with Marfan's syndromeRonald V Lacro, Harry C Dietz, Lynn A Sleeper, et al.American Journal of Human Genetics|January 31, 2017
A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental DelayKelly Schoch, Linyan Meng, Szabolcs Szelinger, et al.Pageof 5